149 related articles for article (PubMed ID: 2583282)
1. Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development.
Rothman RB; Mele A; Reid AA; Akunne H; Greig N; Thurkauf A; Rice KC; Pert A
FEBS Lett; 1989 Nov; 257(2):341-4. PubMed ID: 2583282
[TBL] [Abstract][Full Text] [Related]
2. GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine.
Rothman RB; Mele A; Reid AA; Akunne HC; Greig N; Thurkauf A; de Costa BR; Rice KC; Pert A
Pharmacol Biochem Behav; 1991 Oct; 40(2):387-97. PubMed ID: 1839568
[TBL] [Abstract][Full Text] [Related]
3. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?
Sharif NA; Nunes JL; Kalfayan V; McClelland DL; Rosenkranz RP; Eglen RM; Whiting RL
Neurochem Int; 1992 Jul; 21(1):69-73. PubMed ID: 1303143
[TBL] [Abstract][Full Text] [Related]
4. Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter.
Rothman RB; Grieg N; Kim A; De Costa BR; Rice KC; Carroll FI; Pert A
Pharmacol Biochem Behav; 1992 Dec; 43(4):1135-42. PubMed ID: 1475296
[TBL] [Abstract][Full Text] [Related]
5. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
[TBL] [Abstract][Full Text] [Related]
6. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.
Valchar M; Hanbauer I
J Neurochem; 1993 Feb; 60(2):469-76. PubMed ID: 8419533
[TBL] [Abstract][Full Text] [Related]
7. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
Xu C; Coffey LL; Reith ME
Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
[TBL] [Abstract][Full Text] [Related]
8. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
[TBL] [Abstract][Full Text] [Related]
9. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
Matecka D; Lewis D; Rothman RB; Dersch CM; Wojnicki FH; Glowa JR; DeVries AC; Pert A; Rice KC
J Med Chem; 1997 Feb; 40(5):705-16. PubMed ID: 9057857
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909).
Zhang Y; Rothman RB; Dersch CM; de Costa BR; Jacobson AE; Rice KC
J Med Chem; 2000 Dec; 43(25):4840-9. PubMed ID: 11123994
[TBL] [Abstract][Full Text] [Related]
11. Iron deficiency alters dopamine transporter functioning in rat striatum.
Erikson KM; Jones BC; Beard JL
J Nutr; 2000 Nov; 130(11):2831-7. PubMed ID: 11053528
[TBL] [Abstract][Full Text] [Related]
12. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
13. Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters.
Rothman RB; Lewis B; Dersch C; Xu H; Radesca L; de Costa BR; Rice KC; Kilburn RB; Akunne HC; Pert A
Synapse; 1993 May; 14(1):34-9. PubMed ID: 8511716
[TBL] [Abstract][Full Text] [Related]
14. Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents.
Lewis DB; Matecka D; Zhang Y; Hsin LW; Dersch CM; Stafford D; Glowa JR; Rothman RB; Rice KC
J Med Chem; 1999 Dec; 42(24):5029-42. PubMed ID: 10585212
[TBL] [Abstract][Full Text] [Related]
15. Studies of the biogenic amine transporters. II. A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists.
Rothman RB; Becketts KM; Radesca LR; de Costa BR; Rice KC; Carroll FI; Dersch CM
Life Sci; 1993; 53(17):PL267-72. PubMed ID: 8412496
[TBL] [Abstract][Full Text] [Related]
16. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain.
Tsukada H; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Harada N; Nakanishi S
Brain Res; 1999 Dec; 849(1-2):85-96. PubMed ID: 10592290
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of [3H]dopamine translocation and [3H]cocaine analog binding: a potential screening device for cocaine antagonists.
Reith ME; Xu C; Carroll FI; Chen NH
Methods Enzymol; 1998; 296():248-59. PubMed ID: 9779453
[No Abstract] [Full Text] [Related]
18. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
[TBL] [Abstract][Full Text] [Related]
19. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter.
Nightingale B; Dersch CM; Boos TL; Greiner E; Calhoun WJ; Jacobson AE; Rice KC; Rothman RB
J Pharmacol Exp Ther; 2005 Aug; 314(2):906-15. PubMed ID: 15860577
[TBL] [Abstract][Full Text] [Related]
20. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
Kula NS; Baldessarini RJ
Neuropharmacology; 1991 Jan; 30(1):89-92. PubMed ID: 2046881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
